In our nationwide population-based cohort study, we aimed to investigate the relationship between xanthine oxidase inhibitor use (either allopurinol or febuxostat) and the risk of infection/sepsis and their related mortality in CKD patients. The gene discussed is XDH; the disease is Sepsis.